MX2019007032A - Operaciones de cosecha mejoradas para proteinas recombinadas. - Google Patents

Operaciones de cosecha mejoradas para proteinas recombinadas.

Info

Publication number
MX2019007032A
MX2019007032A MX2019007032A MX2019007032A MX2019007032A MX 2019007032 A MX2019007032 A MX 2019007032A MX 2019007032 A MX2019007032 A MX 2019007032A MX 2019007032 A MX2019007032 A MX 2019007032A MX 2019007032 A MX2019007032 A MX 2019007032A
Authority
MX
Mexico
Prior art keywords
recombinant protein
host cell
prokaryotic host
filtered bulk
recombinant proteins
Prior art date
Application number
MX2019007032A
Other languages
English (en)
Inventor
w laird Michael
V Gunson Jane
Kaleas Kim
R Snedecor Bradley
St John Richard
Nadarajah Deepa
Adams Rachel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2019007032A publication Critical patent/MX2019007032A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/42Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Sustainable Development (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención contempla un método para la producción de una proteína recombinada que comprende (a) la fermentación de una célula huésped procariota, donde dicha célula huésped procariota ha sido transformada con un ácido nucleico que codifica dicha proteína recombinada, y (b) la cosecha de dicha proteína recombinada en condiciones donde los niveles de dO2 son superiores a 0%, y (c) la purificación de dicha proteína recombinada hasta un volumen filtrado, donde dicho volumen filtrado no contiene una cantidad detectable de aducto de DHNA-proteína recombinada, medida por un ensayo de IEC a 310 nm. La presente invención además contempla un método para la producción de una proteína recombinada que comprende (a) la fermentación de una célula huésped procariota con deleción del gen menE, donde dicha célula huésped procariota ha sido transformada con un ácido nucleico que codifica dicha proteína recombinada, (b) la cosecha de dicha proteína recombinada; y (c) la purificación de dicha proteína recombinada hasta un volumen filtrado, donde dicho volumen filtrado no contiene una cantidad detectable de aducto de DHNA-proteína recombinada, medida por un ensayo de IEC a 310 nm, y donde el rendimiento de proteína recombinada se incrementa alrededor de 20% o más.
MX2019007032A 2012-03-27 2014-09-25 Operaciones de cosecha mejoradas para proteinas recombinadas. MX2019007032A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261616297P 2012-03-27 2012-03-27

Publications (1)

Publication Number Publication Date
MX2019007032A true MX2019007032A (es) 2019-08-16

Family

ID=48040433

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2014011558A MX365947B (es) 2012-03-27 2013-03-14 Operaciones de cosecha mejoradas para proteinas recombinadas.
MX2018007677A MX2018007677A (es) 2012-03-27 2014-09-25 Operaciones de cosecha mejoradas para proteinas recombinadas.
MX2019007032A MX2019007032A (es) 2012-03-27 2014-09-25 Operaciones de cosecha mejoradas para proteinas recombinadas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2014011558A MX365947B (es) 2012-03-27 2013-03-14 Operaciones de cosecha mejoradas para proteinas recombinadas.
MX2018007677A MX2018007677A (es) 2012-03-27 2014-09-25 Operaciones de cosecha mejoradas para proteinas recombinadas.

Country Status (21)

Country Link
US (8) US20140080180A1 (es)
EP (1) EP2831261B1 (es)
JP (4) JP6225162B2 (es)
KR (2) KR102096678B1 (es)
CN (2) CN109880867A (es)
AR (2) AR090340A1 (es)
AU (3) AU2013240280A1 (es)
BR (1) BR112014023176B1 (es)
CA (2) CA3086730A1 (es)
ES (1) ES2654424T3 (es)
HK (1) HK1207120A1 (es)
HR (1) HRP20171966T1 (es)
IL (1) IL234377B (es)
MX (3) MX365947B (es)
MY (1) MY171729A (es)
PL (1) PL2831261T3 (es)
RU (2) RU2017139267A (es)
SG (4) SG10201912877SA (es)
SI (1) SI2831261T1 (es)
WO (1) WO2013148249A1 (es)
ZA (1) ZA201406434B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102499718B1 (ko) * 2016-06-10 2023-02-13 론자 리미티드 단백질을 안정화시키는 방법
TWI763732B (zh) * 2016-11-07 2022-05-11 美商西雅圖遺傳學公司 工程化半胱胺酸帽之分佈
CN111918873A (zh) * 2018-03-27 2020-11-10 百时美施贵宝公司 使用紫外线信号实时监测滴度
CN109725088B (zh) * 2019-03-16 2021-05-18 丁立平 一种测定豆芽中2-萘甲酸及其衍生物的气相色谱-质谱联用法
CN110305903B (zh) * 2019-07-31 2021-10-01 江苏璟泽生物医药有限公司 重组人促卵泡激素及其制备方法
CN113155776A (zh) * 2021-04-29 2021-07-23 华东交通大学 一种柑桔最佳采收期预测方法
FR3146146A1 (fr) 2023-02-24 2024-08-30 Bgene Genetics Production d’acide 1-4-dihydroxy-2-naphtoïque par Escherichia coli

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2036891B (en) 1978-12-05 1983-05-05 Windsor Smith C Change speed gear
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
AU606320B2 (en) 1985-11-01 1991-02-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE69232944T2 (de) 1991-08-14 2003-12-24 Genentech, Inc. Veränderte Immunglobuline für spezifische FC-Epsilon Rezeptoren
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
DE69308573T2 (de) 1992-08-17 1997-08-07 Genentech Inc Bispezifische immunoadhesine
DK0656789T3 (da) 1992-08-21 1998-08-24 Genentech Inc Fremgangsmåde til behandling af en LFA-1-medieretforstyrrelse.
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
CA2176811C (en) 1993-12-10 2008-01-29 David Tai Wai Fei Methods for diagnosis of allergy and screening of anti-allergy therapeutics
EP0739214B1 (en) 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
MX9603773A (es) 1994-03-03 1997-07-31 Genentech Inc Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
WO1996040210A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
JP4864175B2 (ja) 1996-01-23 2012-02-01 ジェネンテック, インコーポレイテッド 発作に関する抗―cd18抗体
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
DE69729209T2 (de) 1996-11-27 2005-05-19 Genentech, Inc., South San Francisco Humanisierte anti-koerper gegen cd11a
DE69829891T2 (de) 1997-04-07 2005-10-06 Genentech, Inc., South San Francisco Anti-VEGF Antikörper
EP0981618B2 (en) 1997-05-15 2011-08-24 Genentech, Inc. Anti-apo-2 antibody
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
BR0015224A (pt) 1999-10-29 2002-07-09 Genentech Inc Anticorpo anti-antìgeno de célula estaminal prostática (psca) isolado, anticorpo monoclonal anti-psca, ácido nucleico isolado, vetor de expressão, célula, célula hospedeira, método de produção de anticorpo, composição método in vitro para matar uma célula cancerosa que expresse psca, uso de uma anticorpo monoclonal anti-psca e artigo industrializado
US6946271B2 (en) * 2000-09-20 2005-09-20 Degussa Ag Nucleotide sequences which code for the menE gene
US6979556B2 (en) 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
HUE035898T2 (en) 2002-12-16 2018-05-28 Genentech Inc Immunoglobulin variants and their applications
WO2004085364A1 (ja) * 2003-03-26 2004-10-07 Meiji Dairies Corporation 1,4−ジヒドロキシ−2−ナフトエ酸の安定化方法
ES2281822T3 (es) * 2003-08-13 2007-10-01 Sandoz Ag Vectores de expresion, celulas huesped transformadas y procedimiento de fermentacion para la produccion de polipeptidos recombinantes.
AU2005212237B2 (en) * 2004-02-04 2009-06-11 Merck Sharp & Dohme Llc Process for large scale production of plasmid DNA by E. coli fermentation
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
CN101115832A (zh) * 2004-11-26 2008-01-30 协和发酵工业株式会社 工业上有用的微生物
CN105884904B (zh) * 2006-05-05 2020-06-16 冈戈根股份有限公司 噬菌体衍生的抗微生物活性剂
JP5305615B2 (ja) * 2006-06-05 2013-10-02 株式会社Adeka メナキノンの新規生合成経路に関与するタンパク質の遺伝子群を利用したメナキノンの製造方法
NZ573639A (en) * 2006-07-14 2012-03-30 Genentech Inc Refolding of recombinant proteins
SI2586788T1 (en) * 2007-07-09 2018-07-31 Genentech, Inc. Prevention of the reduction of the disulfide bond during the recombinant production of polypeptides
CN101665798B (zh) * 2008-09-06 2012-11-21 浙江我武生物科技股份有限公司 一种制备重组人血清白蛋白与干扰素α融合蛋白的方法
CN101503470A (zh) * 2008-09-27 2009-08-12 上海交通大学 rhDSL重组蛋白及其制备方法
JP2010088387A (ja) * 2008-10-10 2010-04-22 Waseda Univ 放線菌内で目的タンパク質を誘導発現可能なプロモーター

Also Published As

Publication number Publication date
US20210171997A1 (en) 2021-06-10
JP2018046825A (ja) 2018-03-29
US20200199639A1 (en) 2020-06-25
CN104350156A (zh) 2015-02-11
CA2866753A1 (en) 2013-10-03
EP2831261A1 (en) 2015-02-04
US20230069966A1 (en) 2023-03-09
CA3086730A1 (en) 2013-10-03
US20240158825A1 (en) 2024-05-16
MX2014011558A (es) 2014-11-14
US20140080180A1 (en) 2014-03-20
WO2013148249A1 (en) 2013-10-03
CN104350156B (zh) 2019-04-02
CA2866753C (en) 2020-09-22
AU2013240280A1 (en) 2014-10-16
BR112014023176A2 (pt) 2017-06-20
US20160130624A1 (en) 2016-05-12
IL234377B (en) 2021-01-31
JP2020202849A (ja) 2020-12-24
SG10201508420VA (en) 2015-11-27
ZA201406434B (en) 2017-08-30
HRP20171966T1 (hr) 2018-02-09
KR20200037425A (ko) 2020-04-08
RU2636353C2 (ru) 2017-11-22
US9765379B2 (en) 2017-09-19
KR20140148392A (ko) 2014-12-31
SG10202007206WA (en) 2020-08-28
RU2014137554A (ru) 2016-05-20
JP2015512259A (ja) 2015-04-27
RU2017139267A (ru) 2019-02-12
SG10201912877SA (en) 2020-02-27
SG11201406112TA (en) 2014-10-30
EP2831261B1 (en) 2017-10-18
ES2654424T3 (es) 2018-02-13
AU2017202484A1 (en) 2017-05-04
MX2018007677A (es) 2020-11-12
MX365947B (es) 2019-06-19
US20150225760A1 (en) 2015-08-13
AU2017202484B2 (en) 2019-06-13
US20180291411A1 (en) 2018-10-11
AR116615A2 (es) 2021-05-26
CN109880867A (zh) 2019-06-14
JP6225162B2 (ja) 2017-11-01
BR112014023176B1 (pt) 2021-09-28
AR090340A1 (es) 2014-11-05
SI2831261T1 (en) 2018-01-31
PL2831261T3 (pl) 2018-04-30
AU2019226192A1 (en) 2019-09-26
JP2019141049A (ja) 2019-08-29
MY171729A (en) 2019-10-25
KR102096678B1 (ko) 2020-04-02
HK1207120A1 (en) 2016-01-22

Similar Documents

Publication Publication Date Title
MX2019007032A (es) Operaciones de cosecha mejoradas para proteinas recombinadas.
MX2015017110A (es) Integracion dirigida.
MX2019004568A (es) Produccion mejorada de derivados de acidos grasos.
MX369726B (es) Polipéptidos con actividad proteasa.
MY187542A (en) Carbohydrate degrading polypeptide and uses thereof
MX353710B (es) Polipeptidos que tienen actividad de lisozima y polinucleotidos que los codifican.
MX2013007853A (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
EP3130598A3 (en) Expression sequences
MX337919B (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
NZ742660A (en) Variants of chymosin with improved milk-clotting properties
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
MX337913B (es) Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos.
IN2012DN03823A (es)
NZ700897A (en) Lowering saturated fatty acid content of plant seeds
GB201003701D0 (en) System for the expression of a protein
WO2013189972A3 (en) Use of polypeptides having protease activity in animal feed and detergents
WO2014122161A3 (en) Use of polypeptides having protease activity in animal feed
MX357655B (es) Mediador soluble.
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
EA033437B1 (ru) Fc-гамма-рецептор iib и его применение для лечения или предупреждения воспалительных и/или аутоиммунных заболеваний
MX2015015274A (es) Ruta de ácido organico novedosa.
WO2014052923A3 (en) Trophic conversion of photoautotrophic bacteria for improved diurnal properties
MX350391B (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.
MX2014001861A (es) Polipeptidos con actividad proteasa.
NZ707753A (en) Purification of recombinant human galactocerebroside β-galactosidase (rhgalc)